Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 161798-03-4
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
161798-03-4 |
Appearance :: |
White Powder |
Molecular Formula:: |
C18H21NO4S |
Molecular Weight:: |
347.429 |
EINECS NO:: |
700-743-7 |
MDL NO:: |
N/A |
CAS NO:: |
161798-03-4 |
Appearance :: |
White Powder |
Molecular Formula:: |
C18H21NO4S |
Molecular Weight:: |
347.429 |
EINECS NO:: |
700-743-7 |
MDL NO:: |
N/A |
Product Description:
Product Name: Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS NO:161798-03-4
Synonyms:
ethyl 2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate;
Chemical & Physical Properties:
Appearance : white powder
Assay :≥99.0%
Density:1.2g/cm3
Boiling Point:495.9℃ at 760 mmHg
Flash Point:253.7℃
Febuxostat intermediate;
Febuxostat is a new generation of xanthine oxidase inhibitors developed by emperor company of Japan. It is used to treat hyperuricemia (gout) clinically. Its structure is completely different from that of xanthine oxidase inhibitor developed 40 years ago. It is a new and highly effective non purine xanthine oxidase selective inhibitor. Xanthine oxidase is a key enzyme to promote uric acid production.
In February 2009, the U.S. Food and Drug Administration (FDA) approved febuxostat for long-term treatment of gout hyperuricemia patients.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
